APA (7th ed.) Citation

Vinjamuri, S., Gilbert, T. M., Banks, M., McKane, G., Maltby, P., Poston, G., . . . Cuthbertson, D. J. (2013). Peptide receptor radionuclide therapy with 90Y-DOTATATE/90Y-DOTATOC in patients with progressive metastatic neuroendocrine tumours: Assessment of response, survival and toxicity. British Journal of Cancer, 108(7), 1440. https://doi.org/10.1038/bjc.2013.103

Chicago Style (17th ed.) Citation

Vinjamuri, S., et al. "Peptide Receptor Radionuclide Therapy with 90Y-DOTATATE/90Y-DOTATOC in Patients with Progressive Metastatic Neuroendocrine Tumours: Assessment of Response, Survival and Toxicity." British Journal of Cancer 108, no. 7 (2013): 1440. https://doi.org/10.1038/bjc.2013.103.

MLA (9th ed.) Citation

Vinjamuri, S., et al. "Peptide Receptor Radionuclide Therapy with 90Y-DOTATATE/90Y-DOTATOC in Patients with Progressive Metastatic Neuroendocrine Tumours: Assessment of Response, Survival and Toxicity." British Journal of Cancer, vol. 108, no. 7, 2013, p. 1440, https://doi.org/10.1038/bjc.2013.103.